Global Trade Alert
Global Trade Alert

India: Import duty exemption on manufacturing of raw materials to manufacture Amphotericin B and COVID-19 testing kits

Announcement

12 Jul 2021

India has announced a customs duty exemption on the imports of raw materials for manufacturing the drug Amphotericin-B and COVID-19 test kits.

Source

Sign in to access

Number of interventions

2

1 certainly harmful

0 likely harmful

1 liberalising

List of interventions

Implementation date

12 Jul 2021

Revocation date:

30 Sep 2021

Updated: 12 Jul 2021
Tax or social insurance relief

On 12 July 2021, the Indian Ministry of Finance through Notification No. 35/2021-Customs announced an import duty exemption on raw materials for the manufacture of the drug Amphotericin B and of CO...

Sign in to see more

Implementation date

12 Jul 2021

Revocation date:

30 Sep 2021

Updated: 12 Jul 2021
Import tariff

On 12 July 2021, the Indian Ministry of Finance through Notification No. 35/2021-Customs announced a temporary customs duty exemption on certain Active Pharmaceutical Ingredients (APIs) o...

Sign in to see more

Threads

See all

This state act is not part of any Thread yet.